SpaceX reportedly proposed investing $1.5 billion in Vietnam tied to its Starlink rollout, with the company also exploring ...

Find insight on Novo Nordisk, product-specific tariffs, Pro Medicus and more in the latest Market Talks on Health Care.

EuroCham Vietnam announced yesterday, 24 March 2025, its new 17-member executive board for the 2025 term. The Board included ...

Meanwhile, LEGO (Denmark) is constructing a carbon-neutral factory in Binh Duong-an iconic project representing Nordic businesses’ commitment to sustainable development in Vietnam. Other leading ...

The popularity of Novo Nordisk's Ozempic and Wegovy has attracted competitors and created supply constraints. Novo Nordisk's next-generation weight loss drug disappointed investors in Phase III ...

There is a long-running health crisis impacting the modern world. According to the World Health Organization, one in eight people worldwide were living with obesity as of 2022. Obesity causes ...

Novo Nordisk on Monday announced a $2 billion deal with a Chinese company making a drug in the same GLP-1 space where the ...

Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors’ perception of the ...

Pharmaceutical giant Novo Nordisk (NYSE: NVO) built its business on insulin and has emerged as a leading innovator in GLP-1 agonists, relatively new drugs that treat obesity and type 2 diabetes by ...

The Novo Nordisk Foundation’s project to explore food processing has created some controversy of late. Initially, the project was framed as ‘the next generation’ of the ‘Nova’ classification, with its ...

Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity and diabetes drug, the company announced March 24. The drug ...